Black tea consumption and serum cholesterol concentration: Systematic review and meta-analysis of randomized controlled trials

Clinical Nutrition

Volumn 34, Issue 4, 2015, Pages 612-619

  Zhao, Yimin ^a   Asimi, Sailimuhan ^a   Wu, Kejian ^a   Zheng, Jusheng ^a   Li, Duo ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Black tea; Cholesterol; Meta analysis; Systematic review

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TEA; TRIACYLGLYCEROL;

ARTICLE; BLACK TEA CONSUMPTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; FOOD INTAKE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NUTRITIONAL HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW; TEA; THERAPY EFFECT; BLOOD; CAMELLIA SINENSIS; CARDIOVASCULAR DISEASES; CHEMISTRY; FACTUAL DATABASE; RISK FACTOR;

CAMELLIA SINENSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DATABASES, FACTUAL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TEA; TRIGLYCERIDES;

EID: 84930760722     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.06.003     Document Type: Article

References (41)

1. Balentine D.A., Wiseman S.A., Bouwens L.C. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 1997, 37:693-704.
2. Higdon J.V., Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003, 43:89-143.
3. Balentine D.A. Manufacturing and chemistry of tea. ACS symposium series 1992, 102. ACS Publications.
4. Huxley R., Lee C.M., Barzi F., Timmermeister L., Czernichow S., Perkovic V., et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 2009, 169:2053-2063.
5. Arab L., Liu W., Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 2009, 40:1786-1792.
6. Grassi D., Mulder T.P., Draijer R., Desideri G., Molhuizen H.O., Ferri C. Black tea consumption dose-dependently improves flow-mediated dilation in healthy males. JHypertens 2009, 27:774-781.
7. Kannel W.B., Castelli W.P., Gordon T., McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971, 74:1-12.
8. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993, 269:3015-3023.
9. Jia L., Liu X., Bai Y.Y., Li S.H., Sun K., He C., et al. Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2010, 92:218-225.
10. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269.
11. Higgins J.P., Green S. Cochrane handbook for systematic reviews of interventions 2008, Collaboration C, Wiley Online Library.
12. Moher D., Pham B., Jones A., Cook D.J., Jadad A.R., Moher M., et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998, 352:609-613.
13. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
14. Begg C.B., Berlin J.A. Publication bias and dissemination of clinical research. JNatl Cancer Inst 1989, 81:107-115.
15. Duval S., Tweedie R. Trim and fill: a simple funnel plot based method of testing and adjusting for publication bias in meta-analyses. Biometrics 2000, 56:455-463.
16. Bahorun T., Luximon-Ramma A., Neergheen-Bhujun V.S., Gunness T.K., Googoolye K., Auger C., et al. The effect of black tea on risk factors of cardiovascular disease in a normal population. Prev Med 2012, 54(Suppl.):S98-S102.
17. Bingham S.A., Vorster H., Jerling J.C., Magee E., Mulligan A., Runswick S.A., et al. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr 1997, 78:41-55.
18. Davies M.J., Judd J.T., Baer D.J., Clevidence B.A., Paul D.R., Edwards A.J., et al. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. JNutr 2003, 133:3298S-3302S.
19. Duffy S.J., Keaney J.J., Holbrook M., Gokce N., Swerdloff P.L., Frei B., et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001, 104:151-156.
20. Hodgson J.M., Puddey I.B., Burke V., Watts G.F., Beilin L.J. Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci 2002, 102:195-201.
21. Ishikawa T., Suzukawa M., Ito T., Yoshida H., Ayaori M., Nishiwaki M., et al. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 1997, 66:261-266.
22. Mukamal K.J., MacDermott K., Vinson J.A., Oyama N., Manning W.J., Mittleman M.A. A6-month randomized pilot study of black tea and cardiovascular risk factors. Am Heart J 2007, 154:721-724.
23. Princen H.M., van Duyvenvoorde W., Buytenhek R., Blonk C., Tijburg L.B., Langius J.A., et al. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 1998, 18:833-841.
24. Trautwein E.A., Du Y., Meynen E., Yan X., Wen Y., Wang H., et al. Purified black tea theaflavins and theaflavins/catechin supplements did not affect serum lipids in healthy individuals with mildly to moderately elevated cholesterol concentrations. Eur J Nutr 2010, 49:27-35.
25. van Het H.K., de Boer H.S., Wiseman S.A., Lien N., Westrate J.A., Tijburg L.B. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 1997, 66:1125-1132.
26. McAnlis G.T., McEneny J., Pearce J., Young I.S. Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr 1998, 52:202-206.
27. Mai V., Katki H.A., Harmsen H., Gallaher D., Schatzkin A., Baer D.J., et al. Effects of a controlled diet and black tea drinking on the fecal microflora composition and the fecal bile acid profile of human volunteers in a double-blinded randomized feeding study. JNutr 2004, 134:473-478.
28. Zhong L., Furne J.K., Levitt M.D. An extract of black, green, and mulberry teas causes malabsorption of carbohydrate but not of triacylglycerol in healthy volunteers. Am J Clin Nutr 2006, 84:551-555.
29. Chu S., Fu H., Yang J., Liu G., Dou P., Zhang L., et al. Arandomized double-blind placebo-controlled study of Pu'er tea extract on the regulation of metabolic syndrome. Chin J Integr Med 2011, 17:492-498.
30. Fujita H., Yamagami T. Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 2008, 28:450-456.
31. Kubota K., Sumi S., Tojo H., Sumi-Inoue Y., I-Chin H., Oi Y., et al. Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract. Nutr Res 2011, 31:421-428.
32. Zheng X.X., Xu Y.L., Li S.H., Liu X.X., Hui R., Huang X.H. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr 2011, 94:601-610.
33. de Koning G.J., Uiterwaal C.S., van der Schouw Y.T., Boer J.M., Grobbee D.E., Verschuren W.M., et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol 2010, 30:1665-1671.
34. Stensvold I., Tverdal A., Solvoll K., Foss O.P. Tea consumption. Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 1992, 21:546-553.
35. Peters U., Poole C., Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 2001, 154:495-503.
36. Kobayashi M., Ikegami H., Fujisawa T., Nojima K., Kawabata Y., Noso S., et al. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes 2007, 56:239-247.
37. Koo S.I., Noh S.K. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. JNutr Biochem 2007, 18:179-183.
38. Vinson J.A., Dabbagh Y.A. Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: mechanisms for the epidemiological benefits of tea drinking. FEBS Lett 1998, 433:44-46.
39. Henning S.M., Niu Y., Lee N.H., Thames G.D., Minutti R.R., Wang H., et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr 2004, 80:1558-1564.
40. Hartley L., Flowers N., Holmes J., Clarke A., Stranges S., Hooper L., et al. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013, 6:D9934.
41. Shao W., Powell C., Clifford M.N. The analysis by HPLC of green, black and Pu'er teas produced in Yunnan. JSci Food Agric 1995, 69:535-540.